Drug recall · February 2, 2022
Metoprolol Succinate Extended-Release Tablets recall
Why: Failed Dissolution Specifications.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, Rx Only, 100 Tablets per bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ, 07054, NDC 67877-590-01.
- Lots / codes
Lot #: 21143093, Exp. March 2023
- Quantity
- 9216 bottles
- Company
- Ascend Laboratories, LLC, Parsippany, NJ
- Distribution
- Nationwide in the USA
- Initiated
- January 12, 2022 · Voluntary: Firm initiated
- Classified
- January 21, 2022
- Reported
- February 2, 2022
- Ended
- May 31, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Metoprolol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.